Proof-of-concept Study for BIVV020 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Condition:   Chronic Inflammatory Demyelinating Polyradiculoneuropathy Intervention:   Drug: BIVV020 Sponsor:   Sanofi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2020 Category: Research Source Type: clinical trials

Subcutaneous Immunoglobulin in De-novo CIDP (SIDEC)
Condition:   CIDP - Chronic Inflammatory Demyelinating Polyneuropathy Intervention:   Biological: Immunoglobulin Sponsors:   University of Aarhus;   Rigshospitalet, Denmark;   Aarhus University Hospital;   Odense University Hospital;   Aalborg University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2020 Category: Research Source Type: clinical trials